Cohen & Steers, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDCohen & Steers, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 70), indicating performance broadly in line with the market. Earnings growth of 6% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $76.53 | +3.47% | ABOVE |
| 50 SMA | $73.13 | +8.29% | ABOVE |
| 100 SMA | $68.99 | +14.79% | ABOVE |
| 150 SMA | $67.45 | +17.41% | ABOVE |
| 200 SMA | $67.23 | +17.79% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CNS in an uptrend right now?
CNS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, CNS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is CNS overbought or oversold?
CNS's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is CNS outperforming the market?
CNS has a Relative Strength (RS) Rating of 70 out of 99. CNS is performing about average compared to the market.
Where is CNS in its 52-week range?
CNS is trading at $79.19, which is 98% of its 52-week high ($80.48) and 94% above its 52-week low ($58.39).
How volatile is CNS?
CNS has a Beta of 0.75 and 52-week volatility of 27%. It's less volatile than the S&P 500 - generally more stable.